Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (1)
P 1 (2)
P 2 (3)

Trial Status

Not Yet Recruiting3
Recruiting2
Active Not Recruiting1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07589517Phase 1Recruiting

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

NCT07333053Not ApplicableRecruitingPrimary

Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer

NCT07209384Phase 2Not Yet RecruitingPrimary

Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer

NCT07124884Phase 2Not Yet Recruiting

5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab

NCT07009145Phase 2Not Yet RecruitingPrimary

QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC

NCT06540261Phase 1Active Not RecruitingPrimary

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Showing all 6 trials

Research Network

Activity Timeline